DNA INDEX AND PERCENT-S-PHASE CELLS DETERMINED IN ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDREN - A REPORT FROM STUDIES ALL-V, ALL-VI, AND ALL-VII (1979-1991) OF THE DUTCH CHILDHOOD LEUKEMIA STUDY-GROUP AND THE NETHERLANDS WORKGROUP ON CANCER GENETICS AND CYTOGENETICS

DNA INDEX AND PERCENT-S-PHASE CELLS DETERMINED IN ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDREN - A REPORT FROM STUDIES ALL-V, ALL-VI, AND ALL-VII (1979-1991) OF THE DUTCH CHILDHOOD LEUKEMIA STUDY-GROUP AND THE NETHERLANDS WORKGROUP ON CANCER GENETICS AND CYTOGENETICS
复制标题

DOI:
10.1002/mpo.2950250604
复制
发表时间:
1995-12-01
期刊:
MEDICAL AND PEDIATRIC ONCOLOGY
影响因子:
--
通讯作者:
KAMPS, WA
KAMPS, WA
中科院分区:
其他
文献类型:
--
作者:
SMETS, LA;SLATER, R;KAMPS, WA

文献摘要

被引文献

相似文献

DNA per cell content was routinely recorded by single-parameter flow cytometry in leukemic blasts from 473 children with acute lymphoblastic leukemia (ALL), enrolled in national studies ALL V, VI, and VII (1979-1991) of the Dutch Childhood Leukemia Study Group. The parameters bone-marrow %S-value and DNA Index were compared with clinical features, with chromosome number based on cytogenetic analyses and with treatment results in study ALL VI. %S-values, ranging between 1 and 36%, were unrelated to initial white blood cell count, immunophenotype, and DNA index but were lowest in blasts with L1 morphology. In study ALL VI (non-high risk), the survival of patients with less than or equal to 6% S-phase cells was su period to that of patients with %S-values of > 6 (P = 0.030). Hyperdiploidy, defined by a DNA index greater than or equal to 1.16, was compared to the cytogenetic hyperdiploid classification of n > 50. Initially there were 25 discrepancies in 189 samples jointly analysed by flow cytometry and cytogenetics. After review only five discrepancies remained unresolved. Hyperdiploidy, independent of the method used, was found to be unrelated to blast morphology and %S-phase cells but closely associated with c-ALL and was absent in T-ALL. In study ALL VI, event-free survival at 8 years of hyperdiploid patients was 90.6% but was not significantly different from non-hyperdiploid patients (EFS = 82.1%; P = 0.08). Routine DNA flow cytometry appeared a valuable adjunct to cytogenetic analyses and allowed the identification of a large subset of non-high-risk ALL patients in study ALL VI with a DNA index greater than or equal to 1.16 or %S-value of less than or equal to 6.0 with highest survival probability. (C) 1995 Wiley-Liss, Inc.